References
- Parker G, Crawford J. Judged effectiveness of differing antidepressant strategies by those with clinical depression. Aust N Z J Psychiatry 2007; 41: 32–37
- Trivedi MH, Kleiber BA. Algorithm for the treatment of chronic depression. J Clin Psychiatry 2001; 62(Suppl 6)22–29
- de la Gandara J, Aguera L, Rojo JE, Ros S, de Pedro JM. Use of antidepressant combinations: which, when and why? Results of a Spanish survey. Acta Psychiatr Scand Suppl 2005; 428: 32–26
- Dodd S, Horgan D, Malhi GS, Berk M. To combine or not to combine? A literature review of antidepressant combination therapy. J Affect Disord 2005; 89: 1–11
- Ng F, Dodd S, Berk M. Combination pharmacotherapy in unipolar depression. Expert Rev Neurother 2006; 6: 1049–1060
- Rojo JE, Ros S, Aguera L, de la Gandara J, de Pedro JM. Combined antidepressants: clinical experience. Acta Psychiatr Scand Suppl 2005; 36(428)25–31
- Horgan D, Dodd S, Berk M. A survey of combination antidepressant use in Australia. Australas Psychiatry 2007; 15: 26–29
- Stahl SM. Essential psychopharmacology: neuroscientific basis and practical applications. Cambridge University Press, Cambridge 2000
- Roughead EE, McDermott B, Gilbert AL. Antidepressants: prevalence of duplicate therapy and avoidable drug interactions in Australian veterans. Aust N Z J Psychiatry 2007; 41: 366–370
- Stahl SM. Basic psychopharmacology of antidepressants, part 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 1998; 59(Suppl 4)5–14
- Thase ME. What role do atypical antipsychotic drugs have in treatment-resistant depression?. J Clin Psychiatry 2002; 63: 95–103
- Machado M, Iskedjian M, Ruiz I, Einarson TR. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials. Curr Med Res Opin 2006; 22: 1825–1837
- Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord 2000; 2: 237–248
- Hannan N, Hamzah Z, Akinpeloye HO, Meagher D. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness. J Psychopharmacol 2007; 21: 161–164
- McGrath PJ, Stewart JW, Fava M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry 2006; 163: 1531–1541; quiz 1666
- Ruhe HG, Huyser J, Swinkels JA, Schene AH. Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: systematic review. Br J Psychiatry 2006; 189: 309–316
- Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006; 354: 1231–1242
- Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006; 354: 1243–1252
- Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28–40-